Neutrophil-to-lymphocyte ratio after four weeks of nivolumab administration as a predictive marker in patients with pretreated non-small-cell lung cancer
Takeda, Takayuki, Takeuchi, Mayumi, Saitoh, Masahiko, Takeda, SorouJournal:
Thoracic Cancer
DOI:
10.1111/1759-7714.12838
Date:
August, 2018
File:
PDF, 184 KB
2018